Show 100 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Escudier, Bernard" or (type exact bookEditor and editor="Escudier, Bernard") Add to list Conference Paper C3 A randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (Suniforecast) Marit Ahrens, Bernard Escudier, Ekaterini Boleti, Marc-Oliver Grimm, Marine Gross Goupir, Pilippe Barthelemy, Gwenaelle Gravis, Jens Bedekes, Philipp Ivanyi, Andrej Panic, et al. (2020) ONCOLOGY RESEARCH AND TREATMENT. 43(15 (Suppl. 1)). p.226-226 Add to list Journal Article A1 open access Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma Robert J. Motzer, Nizar M. Tannir, David F. McDermott, Osvaldo Arén Frontera, Bohuslav Melichar, Toni K. Choueiri, Elizabeth R. Plimack, Philippe Barthélémy, Camillo Porta, Saby George, et al. (2018) NEW ENGLAND JOURNAL OF MEDICINE. 378(14). p.1277-1290 Add to list Journal Article A1 open access Nivolumab versus everolimus in advanced renal-cell carcinoma Robert J. Motzer, Bernard Escudier, David F. McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, et al. (2015) NEW ENGLAND JOURNAL OF MEDICINE. 373(19). p.1803-1813 Add to list Journal Article A1 Radiotherapy for renal-cell carcinoma Gert De Meerleer, Vincent Khoo, Bernard Escudier, Steven Joniau, Alberto Bossi, Piet Ost (UGent) , Alberto Briganti, VALERIE FONTEYNE, Marco Van Vulpen, Nicolaas Lumen (UGent) , et al. (2014) LANCET ONCOLOGY. 15(4). p.e170-e177